What your biotech pitch deck needs before slide six

You are raising. The deck is forty slides and investors stop reading at slide six. They nod, they smile, they don't call back. The story lives in your head, not on the page. In Biotech and Life Sciences, you face investors, partners, and customers at once. Each one needs its own version of the same clear story.

You are a founder-scientist. You write for peers, so your deck reads like a lab update. Investors are not peers. They need one idea they can repeat, then the market, the proof, and the ask. In Biotech and Life Sciences, your claims must hold up to scrutiny. That does not mean hiding them. It means stating them so clearly that an investor can cite you without flipping back to slide three.

The work depends on how far your story is from the page. A deck that already has a clear one-liner and clean proof takes less than one where everything lives in your head. In Biotech and Life Sciences, you often have three audiences in one room. Each audience needs its own page and its own version of the story. That adds pages, but not time, when the position is right first. The biggest time cost is the back-and-forth when the story is not clear. So I start there.

This week, cut the deck to ten slides. One idea per slide. If you cannot say your market and proof in two sentences, stop. Do not add more slides. Do not hire a designer to make forty slides pretty. Call SliiceXR. I will shape the story first, then my team designs it to your brand. You get one deck that your investors, partners, and customers each see their way.

You walk into the next meeting with ten clean slides. You say the one idea first. The investor repeats it back to you. Your deck matches your website. Your claims hold. Your story is on the page, not stuck in your head. That is the deck that gets past slide six.

Other questions about creative production for Biotech and Life Sciences